71 |
The role of central catecholamines in performance during prolonged exercise in warm conditionsCordery, Philip January 2013 (has links)
Performance during prolonged exercise capacity diminishes with increasing temperatures. The onset of fatigue under these conditions is not adequately explained by peripheral mechanisms. Recently, drugs which inhibit the reuptake of dopamine and noradrenaline in the brain have been found to improve exercise performance in warm conditions. The aim of this thesis was to further explore and characterise the role of these neurotransmitters during prolonged exercise in warm conditions by manipulating their reuptake or synthesis. The first series of experiments were designed to further investigate the effects of bupropion, a dopamine and noradrenaline reuptake inhibitor, which has been found to improve performance in warm conditions. To explore gender differences in response to acute bupropion administration, the effects of bupropion on prolonged exercise performance in warm conditions in women was investigated in Chapter 3. The results of this study suggest that during the follicular phase of the menstrual cycle, acute administration of bupropion improves exercise performance. To determine whether there are any dose-dependent effects of bupropion, the experiment in Chapter 4 was designed to test three different doses of bupropion. Exercise performance was only improved for the maximal dose, suggesting a threshold for the performance effects of bupropion. Catecholamine precursors do not appear to improve exercise performance as consistently as reuptake inhibitors. In agreement with previous studies, the dopamine precursor L-DOPA did not affect exercise performance in warm conditions in Chapter 5. In Chapter 6 the effect of the atypical antidepressant nutritional supplement S-adenosylmethionine was investigated for its role in the synthesis of dopamine and noradrenaline. S-adenosylmethionine appeared to negatively influence cognitive function, increased skin temperature and circulating prolactin concentrations, but no effects on exercise performance were observed.
|
72 |
Participação da via NTS-PGI-LC-hipocampo (núcleo do trato solitário- núcleo paragigantocelular-Locus coeruleus-hipocampo) na consolidação da memória de reconhecimento de objetosCarpes, Pâmela Billig Mello January 2010 (has links)
Existem crescentes evidências sobre a contribuição da liberação de noradrenalina (NA) central na consolidação das memórias. Teoricamente, o Núcleo do Trato Solitário (NTS) recebe informações e diversos estímulos periféricos, que são então projetados ao Núcleo Paragigantocelular (PGi). Este, por sua vez, utiliza neurotransmissores, predominantemente excitatórios, para influenciar a ativação do Locus Coeruleus (LC). Então, o LC envia projeções noradrenérgicas ao hipocampo e à amígdala, influenciando os processos mnemônicos. Aqui nós demonstramos que a inibição pelo muscimol do NTS, PGi ou LC até 3 horas após o treino na tarefa de reconhecimento de objetos (RO) impede a consolidação da memória medida 24 h após o treino. Adicionalmente, a infusão de timolol, um antagonista de receptores β-adrenérgicos, na região CA1 do hipocampo também impede a consolidação deste tipo de memória. A infusão de NA na região CA1 do hipocampo não altera a retenção da memória, mas, reverte o prejuízo causado pela inibição do NTS, PGi ou LC. A infusão de NMDA no LC após a inibição do NTS ou PGi também reverte essa amnésia. Concomitantemente, verificamos que a inibição NTS, PGi ou LC bloqueia o aumento da expressão do fator neurotrófico derivado do cérebro (BDNF, do inglês brain-derived neurotrophic factor) que ocorre 120 min após o treino na tarefa de reconhecimento de objetos na região CA1 do hipocampo. Também a infusão de NA na região CA1 do hipocampo após a inibição do NTS, PGi ou LC ou de NMDA no LC após a inibição do NTS ou PGi promovem novamente o aumento do BDNF120 min após o treino no RO. Com isso conclui-se que a ativação da via NTS-PGi-LC-Hipocampo é necessária para que ocorra consolidação da memória de RO, na qual desempenha um papel o BDNF hipocampal. / There is evidence of the contribution of brain noradrenaline release (NA) to memory consolidation. The Nucleus of the Solitary Tract (NTS) receives information originated by peripheral stimuli and projects to the Paragigantocellularis Nucleus (PGi), which influences the Locus Coeruleus (LC) through excitatory neurotransmitters. The LC sends noradrenergic projections to the hippocampus and amygdala, influencing the memory processes. Here we show that inhibition by muscimol of NTS, PGi or LC up to 3 h after object recognition training impairs the consolidation of the memory measured 24 h later. Additionally, the infusion of timolol in the CA1 region of hippocampus also inhibits consolidation of this type of memory. The infusion of NA into the CA1 region of hippocampus does not alter memory consolidation of this task, but reverts the deleterious effect of NTS, PGi or LC inhibition. The infusion of NMDA in LC after inhibition of NTS or PGi also reverts the amnesia. Concomitantly, the inhibition of NTS, PGi or LC blocks the increase of brain-derived neurotrophic factor (BDNF) expression in CA1 that occurs 120 min after training in the object recognition task. Further, the infusion of NA in CA1 after inhibition of NTS, PGi or LC; or of NMDA in LC after inhibition of NTS or PGi promotes the BDNF increase seen 120 min after object recognition training. Thus, it is concluded that the activation of NTSPGi- LC-Hippocampus pathway is necessary for consolidation of the object recognition memory, and hippocampal BDNF is involved in this process.
|
73 |
Mecanismos adrenérgicos no núcleo retrotrapezóide no controle respiratório. / Adrenergic mechanisms in the retrotrapezoid nucleus in breathing control.Luiz Marcelo Oliveira Santos 13 November 2015 (has links)
O núcleo retrotrapezóide (RTN) é uma região bulbar envolvida na respiração. Estudos prévios mostraram a presença de varicosidades catecolaminérgicas na região do RTN. O objetivo deste estudo foi investigar a fonte de catecolaminas e os efeitos promovidos pela ativação dos receptores adrenérgicos no RTN. Uma densa projeção neuronal do grupamento A7 para o RTN foi revelada usando o traçador retrógrado Fluorogold. Foi registrada a atividade eletromiográfica do diafragma (DiaEMG) e do abdominal (AbdEMG) de ratos Wistar anestesiados. A injeção de noradrenalina promoveu uma inibição da DiaEMG, sem alterar a AbdEMG; este efeito foi atenuado pela injeção prévia de ioimbina e não foi afetado pela injeção de prazosina e propranolol no RTN. A injeção de fenilefrina no RTN aumentou a DiaEMG e gerou AbdEMG; estes efeitos foram bloqueados por injeções prévias de prazosina no RTN. Os resultados deste estudo suportam a ideia de que o RTN recebe projeções adrenérgicas da ponte que modula a atividade dos neurônios do RTN por meio da ativação dos receptores adrenérgicos α -1 e α- 2. / The retrotrapezoid nucleus (RTN) is a medulla region involved in breathing. Previous studies showed the presence of catecholaminergic varicosities in the RTN region. The aim of this study was to investigate the source of cathecolamines and the effects produced by the activation of adrenergic receptors in the RTN. A dense neuronal projection from A7 to RTN was revealed using retrograde tracer FluorGold. In anaesthetized male Wistar rats, diaphragm (DiaEMG) and abdominal (AbdEMG) muscle activities were recorded. Injection of noradrenaline produced an inhibition of DiaEMG, but did not change AbdEMG; These effects was attenuated by pre-injection of yohimbine and were not affect by injection of prazosin and propranolol into the RTN. Injection of phenilephrine into the RTN increased DiaEMG and was also able to generate AbdEMG; these responses were eliminated by pre-injections of into the RTN. These results support the idea that RTN has pontine adrenergic inputs that modulate RTN neurons activity through activation of α - 1 and - α -2 adrenergic receptors.
|
74 |
L'enrichissement olfactif au cours du vieillissement : implication de la Noradrénaline et modèle de réserve cognitive / Olfactory enrichment during aging : improvement of Noradrenaline and model of cognitive reserveTerrier, Claire 27 November 2018 (has links)
Le vieillissement est un phénomène biologique complexe et inévitable associé à un déclin progressif des fonctions cognitives, sensorielles et motrices qui affecte la qualité de vie et la santé des sujets âgés. Le vieillissement normal s'accompagne de changements structuraux et fonctionnels, conduisant au déclin cognitif. Parmi ces changements, les altérations du système noradrénergique semblent contribuer de façon significative aux déficits cognitifs. Inversement, le maintien de l'intégrité du Locus Coeruleus semble participer à la préservation des performances. Par ailleurs, une stratégie pour promouvoir le bien vieillir propose de booster la réserve cognitive associée à un haut niveau de stimulation cérébrale et à des modulations de l'activation et de la connectivité cérébrales chez l'humain. Chez les rongeurs, l'enrichissement environnemental promouvant les stimulations sensorielles, l'activité motrice et les interactions sociales, mime les conditions de mise en place de la réserve cognitive chez l'homme et a largement montré ses effets bénéfiques sur la cognition. Les objectifs de cette thèse sont premièrement, d'étudier le rôle de la NA dans le maintien de la plasticité structurale et des capacités de discrimination olfactive chez la souris âgée, puis dans un second temps de tester l'enrichissement olfactif comme modèle de construction de la réserve cognitive. Dans une première étude, nous avons utilisé le modèle d'apprentissage perceptif olfactif pour étudier la contribution de la Noradrénaline au maintien de la plasticité structurale et des performances cognitives au cours du vieillissement chez la souris. Cet apprentissage consiste en une amélioration de la discrimination entre deux odorants proches sur le plan perceptif après une exposition répétée à ces odorants. Nos résultats suggèrent que la libération de Noradrénaline dans le bulbe olfactif via une stimulation optogénétique des fibres issues du Locus Coeruleus maintient les capacités de discrimination au cours du vieillissement. Nos données révèlent aussi une forme de plasticité du réseau noradrénergique dans le bulbe olfactif âgé. Ces résultats soutiennent l'hypothèse d'une contribution importante de la Noradrénaline au bien vieillir cérébral. Dans une deuxième étude, nous avons utilisé une stratégie basée sur un enrichissement olfactif, manipulation capable de mobiliser la Noradrénaline, proposé tout au long de la vie de l'animal, dans le but de permettre le développement d'une réserve cognitive. Nos résultats montrent qu'un tel enrichissement améliore les capacités de discrimination olfactive même à un âge avancé. De façon intéressante, les performances non olfactives de mémoire spatiale et de flexibilité sont aussi améliorées. Ces résultats indiquent que les effets bénéfiques de l'enrichissement s'étendent au-delà de la sphère olfactive et incluent des bénéfices sur différentes performances cognitives sensibles à l'âge. Nous proposons donc l'enrichissement olfactif comme un modèle de la construction d'une réserve cognitive qui nous permettra par la suite d'identifier les bases cellulaires du bien vieillir et de tester la contribution de la Noradrénaline dans la construction de la réserve cognitive / Aging is an inevitable and complex biological phenomenon associated with a progressive decline of sensory, motor and cognitive functions with time, affecting life quality and health. Normal brain aging is accompanied by functional and structural changes, leading to cognitive decline. Among these changes, age-related alterations of the noradrenergic system seem to contribute significantly to cognitive deficits. Conversely, the integrity of the Locus Coeruleus seems to allow healthy cognitive aging. A potentially powerful tool to achieve successful brain aging is to boost the cognitive reserve, associated with higher level of brain stimulation and modulations in brain activation and connectivity in humans. In rodents, environmental enrichment, increasing sensory stimulations, motor activity and social interactions, mimics the conditions leading to constitution of the cognitive reserve in humans and has largely proven cognitive benefits.The goals of this thesis are, in the first place, to study the role of Noradrenaline in the maintenance of structural plasticity and olfactory discrimination abilities in aged mice, then secondly, to test the olfactory enrichment as a model of the cognitive reserve build-up.In the first study, we used the olfactory perceptual learning paradigm to investigate the contribution of Noradrenaline to the maintenance of structural plasticity and cognitive abilities during aging in mice. This learning consists in an improvement of the discrimination between perceptually close odorants after repeated exposure to these odorants. Our results suggest that the local release of Noradrenaline in the olfactory bulb, by optogenetic stimulation of Locus Coeruleus fibers allows the maintenance of discrimination abilities during aging. Our data also reveal a form of structural plasticity of the noradrenergic innervation in the aged olfactory bulb. The overall work supports a contribution of Noradrenaline to healthy brain aging.In a second study, we used a strategy based on repeated olfactory enrichment during the whole life of the animal in order to enable the cognitive reserve buildup. Such enrichment maintained olfactory discrimination performances at late ages. Interestingly, mice’s performances in spatial memory and cognitive flexibility improved too. This result indicates that the benefits of an odor-based enrichment extend beyond the olfactory sphere and include broader cognitive benefits on age-sensitive functions. We thus propose lifelong olfactory enrichment as model of the cognitive reserve build-up to further identify its cellular basis and test the contribution of Noradrenaline to cognitive reserve build-up and healthy brain aging
|
75 |
Etude du mécanisme d'action du propranolol dans les hémangiomes infantiles / Study of the mechnism of action of propranolol in infantile hemangiomasKaulanjan-Checkmodine, Priscilla 28 November 2018 (has links)
Touchant près de 3 à 10 % des nouveau-nés, les hémangiomes infantiles (HI) sont des tumeurs vasculaires bénignes, les plus fréquentes chez les nourrissons. Les HI sévères sont actuellement traités par un bêtabloqueur, le propranolol, dont l’efficacité a été découverte de manière fortuite. Ainsi, son mécanisme d’action est méconnu. Le propranolol se fixe sur les récepteurs beta-adrénergiques et empêche leur activation par les catécholamines comme la noradrénaline. Nous nous sommes donc interrogés sur la relation entre le propranolol et la noradrénaline dans cette tumeur. Nous avons montré une forte expression de la noradrénaline et des enzymes de synthèse des catécholamines dans les HI, comparés aux hémangiomes congénitaux, qui diminuent lorsque la tumeur involue ou est traitée par le propranolol. Nous avons ensuite réalisé un modèle in vitro ressemblant à l’HI à partir de cellules isolées d’HI capables de synthétiser les catécholamines : les cellules endothéliales et les péricytes. Ce modèle nous permettra d’étudier l’impact de la noradrénaline et du propranolol sur ces cellules. Parallèlement, notre équipe a réalisé un modèle in vivo qui a permis de mettre en évidence le rôle clé de la protéine quaporine-1 (AQP1) dans la réponse antitumorale du propranolol. Nous avons également étudié l’expression de l’AQP1 dans les HI et les hémangiomes congénitaux et découvert un type cellulaire adventitiel exprimant l’AQP1 dans les HI, le télocyte. Au total, notre travail sur l’HI a mis en évidence d’une part une possibilité de production endogène accrue de noradrénaline, probablement antagonisée avec succès par le propranolol, et la découverte de télocytes AQP1+ qui pourraient avoir un rôle dans la spécificité de la réponse des HI au propranolol. / Affecting nearly 3 to 10 % of newborns, infantile hemangiomas (HI) are the most common benign vascular tumors in infants. Severe HIs are currently treated with a beta-blocker, propranolol, whose efficacy was discovered by serendipidity. Propranolol binds to beta-adrenergic receptors and prevents their activation by catecholamines such as noradrenaline. We therefore wondered about the relationship between propranolol and noradrenaline in this tumor. We showed a strong expression of noradrenaline and catecholamine synthesis enzymes in HI, compared to congenital hemangiomas, which decrease when the tumor involutes or is treated with propranolol. We then realize an in vitro model resembling HI from cells isolated from HI capable of synthesizing catecholamines: endothelial cells and pericytes. This model will permit to study the impact of noradrenaline and propranolol on these cells. At the same time, our team created an in vivo model that highlighted the key role of aquaporin-1 protein (AQP1) in the antitumor response to propranolol. We have also studied the expression of AQP1 in HI and congenital hemangiomas, and discovered an adventitious cell type expressing AQP1 in HI, the telocyte. Altogether, our work on HI has revealed firstly the possibility of increased endogenous production of norepinephrine, probably successfully antagonized by propranolol, and secondly the presence of AQP1 + cells which could have a central role central in the specificity of HI response to propranolol.
|
76 |
The renal sympathetic nerves : implications for vascular remodelling in the SHR kidneyShweta, Amany, 1971- January 2001 (has links)
Abstract not available
|
77 |
The dextroamphetamine response in human subjects : a psychological, psychophysiological and neuroendocrine study / by David JacobsJacobs, David (David Lynden) January 1985 (has links)
Bibliography: leaves 317-350 / 350 leaves : / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Thesis (M.D.)--University of Adelaide, 1986
|
78 |
A Study of Corticotropin-releasing Factor-catecholamine Interactions in the Reinstatement of Cocaine Seeking in RatsBrown, Zenya 06 December 2012 (has links)
It has been well established that the stress-related neurochemical systems corticotropin-releasing factor (CRF), noradrenaline (NA), and dopamine (DA) mediate stress-induced reinstatement of drug seeking. The three series of experiments presented in this dissertation constitute a further exploration of the role these neurochemical circuits play in reinstatement by providing the first direct exploration of whether central CRF and catecholamine (NA and DA) systems interact to influence reinstatement of cocaine seeking.
The primary objective of the first series of experiments was to determine whether NA and CRF systems interact to mediate reinstatement of cocaine seeking and, if so, to determine the direction of this interaction. Results showed that central administration of NA induced reinstatement and up-regulated the expression of c-fos mRNA, a marker of neuronal activation, in brain regions involved in footshock-induced reinstatement. Pretreatment with a CRF antagonist blocked NA-induced reinstatement. In contrast, pretreatment with the α2-adrenoceptor agonist, clonidine, failed to block CRF-induced reinstatement. Taken together, these findings suggest a functional interaction between NA and CRF systems in mediating stress-induced reinstatement of cocaine seeking, whereby activation of CRF receptors occurs subsequent to, and downstream of, the sites of action of NA.
A second series of experiments examined the role of D1- and D2-like receptors in CRF-induced reinstatement. Pretreatment with the D1- or D2-like receptor antagonists, SCH23390 and raclopride, respectively, dose-dependently blocked CRF-induced reinstatement of cocaine seeking. Taken together with previous findings, these results suggest that CRF-induced reinstatement of cocaine seeking likely involves DAergic signaling via D1- and D2-like receptors, subsequent to activation of CRF receptors.
The final series of experiments investigated the neuropharmacology of yohimbine-induced reinstatement, focusing on the roles of α2-adrenoceptors, D1- and D2-like receptors. These experiments were prompted by an unexpected finding in the first series of experiments, in which a CRF antagonist failed to interfere in yohimbine-induced reinstatement of cocaine seeking. Results showed that pretreatment with the α2-adrenoceptor agonist, clonidine, or raclopride, prior to tests for yohimbine-induced reinstatement failed to influence responding. In contrast, pretreatment with SCH23390 blocked yohimbine-induced reinstatement. Taken together, these findings suggest that yohimbine may act through system(s) other than NA to have its effects.
|
79 |
A Study of Corticotropin-releasing Factor-catecholamine Interactions in the Reinstatement of Cocaine Seeking in RatsBrown, Zenya 06 December 2012 (has links)
It has been well established that the stress-related neurochemical systems corticotropin-releasing factor (CRF), noradrenaline (NA), and dopamine (DA) mediate stress-induced reinstatement of drug seeking. The three series of experiments presented in this dissertation constitute a further exploration of the role these neurochemical circuits play in reinstatement by providing the first direct exploration of whether central CRF and catecholamine (NA and DA) systems interact to influence reinstatement of cocaine seeking.
The primary objective of the first series of experiments was to determine whether NA and CRF systems interact to mediate reinstatement of cocaine seeking and, if so, to determine the direction of this interaction. Results showed that central administration of NA induced reinstatement and up-regulated the expression of c-fos mRNA, a marker of neuronal activation, in brain regions involved in footshock-induced reinstatement. Pretreatment with a CRF antagonist blocked NA-induced reinstatement. In contrast, pretreatment with the α2-adrenoceptor agonist, clonidine, failed to block CRF-induced reinstatement. Taken together, these findings suggest a functional interaction between NA and CRF systems in mediating stress-induced reinstatement of cocaine seeking, whereby activation of CRF receptors occurs subsequent to, and downstream of, the sites of action of NA.
A second series of experiments examined the role of D1- and D2-like receptors in CRF-induced reinstatement. Pretreatment with the D1- or D2-like receptor antagonists, SCH23390 and raclopride, respectively, dose-dependently blocked CRF-induced reinstatement of cocaine seeking. Taken together with previous findings, these results suggest that CRF-induced reinstatement of cocaine seeking likely involves DAergic signaling via D1- and D2-like receptors, subsequent to activation of CRF receptors.
The final series of experiments investigated the neuropharmacology of yohimbine-induced reinstatement, focusing on the roles of α2-adrenoceptors, D1- and D2-like receptors. These experiments were prompted by an unexpected finding in the first series of experiments, in which a CRF antagonist failed to interfere in yohimbine-induced reinstatement of cocaine seeking. Results showed that pretreatment with the α2-adrenoceptor agonist, clonidine, or raclopride, prior to tests for yohimbine-induced reinstatement failed to influence responding. In contrast, pretreatment with SCH23390 blocked yohimbine-induced reinstatement. Taken together, these findings suggest that yohimbine may act through system(s) other than NA to have its effects.
|
80 |
Vasomotor responses of rat skeletal muscle arterioles to norepinephrine and adenosineAaker, Aaron Paul, January 2001 (has links)
Thesis (Ph. D.)--University of Missouri--Columbia, 2001. / Typescript. Vita. Includes bibliographical references (leaves 122-137). Also available on the Internet.
|
Page generated in 0.2605 seconds